Otis Worldwide
OTIS
65.74
-0.71
-1.07%
Otis Worldwide
US · OTIS
#808 by market cap
Listed 1970
65.74
-0.71
-1.07%
Live - 5344 symbols - heartbeat 304s ago
· 2026-10-08 08:23
Pre-market
65.74
0.00%
After-hours
65.74
0.00%
Overnight
65.51
-0.35%
- Market cap
- 25.03B
- P/E (TTM)i
- 16.90
- P/Bi
- -4.35
- EPSi
- 3.50
- Div yieldi
- 2.59%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on OTIS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.80, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.19% YoY
Margins
- Gross margin
- 30.28%
- Operating margin
- 15.38%
- Net margin
- 9.59%
Key ratios & quality
- Enterprise valuei
- 32.04B
- PEG ratioi
- 5.01
- Altman Z-Scorei
- 2.80
PEG uses trailing P/E against the 3-year net income growth rate (3.37%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12.92B | 13.12B | 12.76B | 14.30B | 13.69B | 14.21B | 14.26B | 14.43B |
| Gross profit | 3.73B | 3.83B | 3.78B | 4.19B | 3.92B | 4.19B | 4.26B | 4.37B |
| Selling & admin expenses | 1.74B | 1.81B | 1.92B | 1.95B | 1.73B | 1.82B | 1.82B | 1.89B |
| Research & development | 181.00M | 163.00M | 152.00M | 159.00M | 150.00M | 144.00M | 152.00M | 152.00M |
| Operating profit | 1.84B | 1.81B | 1.64B | 2.11B | 2.07B | 2.25B | 2.05B | 2.22B |
| Pretax profit | 1.89B | 1.86B | 1.51B | 1.96B | 1.89B | 2.03B | 2.04B | 1.93B |
| Tax | 683.00M | 594.00M | 455.00M | 541.00M | 519.00M | 533.00M | 305.00M | 479.00M |
| Net profit | 1.21B | 1.27B | 1.06B | 1.42B | 1.37B | 1.50B | 1.73B | 1.46B |
| Basic EPS | 2 | 3 | 2 | 3 | 3 | 3 | 4 | 4 |
| Diluted EPS | 2.42 | 2.58 | 2.08 | 2.89 | 2.96 | 3.39 | 4.07 | 3.50 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.35B | 3.60B | 3.69B | 3.80B | 3.57B | 3.86B |
| Gross profit | 1.00B | 1.09B | 1.13B | 1.15B | 1.08B | 1.14B |
| Selling & admin expenses | 464.00M | 499.00M | 504.00M | 426.00M | 510.00M | 520.00M |
| Research & development | 37.00M | 38.00M | 36.00M | 41.00M | 38.00M | 39.00M |
| Operating profit | 411.00M | 547.00M | 586.00M | 675.00M | 539.00M | 575.00M |
| Pretax profit | 366.00M | 521.00M | 521.00M | 526.00M | 480.00M | 547.00M |
| Tax | 110.00M | 98.00M | 129.00M | 142.00M | 127.00M | 98.00M |
| Net profit | 256.00M | 423.00M | 392.00M | 384.00M | 353.00M | 449.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.61 | 0.99 | 0.95 | 0.95 | 0.87 | 1.12 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.61B | 5.66B | 6.49B | 8.26B | 6.14B | 6.40B | 7.67B | 6.50B |
| Cash & ST investments | 1.33B | 1.45B | 1.78B | 1.57B | 1.19B | 1.27B | 2.30B | 1.10B |
| Inventory | 637.00M | 571.00M | 659.00M | 622.00M | 617.00M | 612.00M | 557.00M | 613.00M |
| Total assets | 9.14B | 9.69B | 10.71B | 12.28B | 9.82B | 10.12B | 11.32B | 10.65B |
| Total current liabilities | 5.30B | 5.37B | 6.67B | 6.25B | 6.84B | 6.48B | 7.75B | 7.66B |
| Short-term debt | 27.00M | 174.00M | 868.00M | 205.00M | 797.00M | 149.00M | 1.47B | 1.21B |
| Long-term debt | -- | 5.00M | 5.26B | 7.25B | 6.10B | 6.87B | 6.97B | 6.90B |
| Total liabilities | 6,920,000,000.00 | 7,361,000,000.00 | 13,911,000,000.00 | 15,263,000,000.00 | 14,483,000,000.00 | 14,837,000,000.00 | 16,044,000,000.00 | 15,924,000,000.00 |
| Total equity | 2.22B | 2.33B | -3.20B | -2.98B | -4.66B | -4.72B | -4.73B | -5.27B |
| Retained earnings | -- | 0 | -3.11B | -2.26B | -2.87B | -2.01B | -978.00M | -440.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 7.44B | 6.39B | 6.61B | 6.50B | 6.46B | 6.84B |
| Cash & ST investments | 1.92B | 688.00M | 840.00M | 1.10B | 834.00M | 813.00M |
| Inventory | 586.00M | 602.00M | 640.00M | 613.00M | 669.00M | 686.00M |
| Total assets | 11.18B | 10.50B | 10.77B | 10.65B | 10.54B | 11.16B |
| Total current liabilities | 7.89B | 7.25B | 7.07B | 7.66B | 7.72B | 8.23B |
| Short-term debt | 1.48B | 675.00M | 492.00M | 1.21B | 939.00M | 1.39B |
| Long-term debt | 6.92B | 7.07B | 7.59B | 6.90B | 6.88B | 7.05B |
| Total liabilities | 16,169,000,000.00 | 15,699,000,000.00 | 16,057,000,000.00 | 15,924,000,000.00 | 15,977,000,000.00 | 16,610,000,000.00 |
| Total equity | -4.99B | -5.20B | -5.29B | -5.27B | -5.44B | -5.45B |
| Retained earnings | -889.00M | -663.00M | -453.00M | -440.00M | -378.00M | -117.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.55B | 1.47B | 1.48B | 1.75B | 1.56B | 1.63B | 1.56B | 1.60B |
| Depreciation & amortization | 190.00M | 180.00M | 191.00M | 203.00M | 191.00M | 193.00M | 181.00M | 175.00M |
| Free cash flow | 1.38B | 1.32B | 1.30B | 1.59B | 1.45B | 1.49B | 1.44B | 1.44B |
| Dividends paid | 0 | 0 | -260.00M | -393.00M | -465.00M | -539.00M | -606.00M | -647.00M |
| Stock buybacks / issuance | -- | 0 | 0 | -725.00M | -850.00M | -800.00M | -1.01B | -809.00M |
| Ending cash balance | 1.33B | 1.45B | 1.78B | 1.57B | 1.19B | 1.27B | 2.30B | 1.10B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 190.00M | 215.00M | 374.00M | 817.00M | 413.00M | 267.00M |
| Depreciation & amortization | 42.00M | 44.00M | 44.00M | 45.00M | 41.00M | 42.00M |
| Free cash flow | 156.00M | 179.00M | 337.00M | 772.00M | 380.00M | 223.00M |
| Dividends paid | -155.00M | -164.00M | -164.00M | -164.00M | -163.00M | -167.00M |
| Stock buybacks / issuance | -253.00M | -308.00M | -248.00M | 0 | -400.00M | -407.00M |
| Ending cash balance | 1.92B | 688.00M | 840.00M | 1.10B | 834.00M | 813.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 66.86 | 60.26 | -- | -- | -- | -- | -- | -- |
| ROA %i | 11.48 | 10.47 | 8.88 | 10.84 | 11.34 | 14.11 | 15.35 | 12.60 |
| ROIC %i | 65.73 | 50.59 | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.21 | 14.48 | 12.85 | 14.74 | 14.86 | 15.38 | 14.38 | 15.38 |
| FCF / sales %i | 10.67 | 10.09 | 10.17 | 11.15 | 10.56 | 10.48 | 10.08 | 10.01 |
| Current ratioi | 1.06 | 1.05 | 0.97 | 1.32 | 0.90 | 0.99 | 0.99 | 0.85 |
| Quick ratioi | 0.89 | 0.90 | 0.81 | 0.86 | 0.76 | 0.85 | 0.83 | 0.72 |
| Debt / assetsi | 0.30 | 5.83 | 60.66 | 63.44 | 73.43 | 72.23 | 77.25 | 79.89 |
| LT debt / equityi | -- | 23.00 | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -- | 48.72 | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | 1.16 | 3.45 | 1.42 | 3.66 | -0.09 | 1.79 |
| Net income CAGR (3Y) %i | -- | -- | 12.52 | 5.90 | 3.94 | 15.78 | 9.70 | 3.37 |
| FCF CAGR (3Y) %i | -- | -- | -0.51 | 4.97 | 2.96 | 4.71 | -3.40 | -0.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 14.64 | 14.87 | 12.81 | 12.60 | 13.64 | 14.00 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.53 | 13.38 | 14.80 | 15.38 | 16.02 | 15.93 |
| FCF / sales %i | 10.25 | 9.51 | 9.25 | 10.01 | 11.39 | 11.48 |
| Current ratioi | 0.94 | 0.88 | 0.94 | 0.85 | 0.84 | 0.83 |
| Quick ratioi | 0.78 | 0.71 | 0.76 | 0.72 | 0.71 | 0.68 |
| Debt / assetsi | 78.06 | 77.41 | 78.80 | 79.89 | 77.95 | 79.29 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Service is the largest reported line at 66.86% of revenue, across 2 reported segments.
- New equipment follows at 33.14%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Service66.86%
New equipment33.14%
Quote time 2026-10-08 08:23:58 · For reference only, not investment advice and not tailored to your situation.